Subject of the day
EUZ.DE
Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration-related sources for radioisotopes. In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
| Line | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|
| Revenue | $68.19M | $80.61M | $75.31M | $87.84M |
| Gross profit | $34.08M | $39.39M | $34.15M | $45.35M |
| Operating income | $15.75M | $18.53M | $15.31M | $25.69M |
| Net income | $9.69M | $11.71M | $8.46M | $18.91M |
| Diluted EPS | 0.15 | 0.19 | 0.13 | — |
| Free cash flow | $2.09M | $9.63M | $10.61M | $10.05M |
| CapEx | -$4.86M | -$5.49M | -$6.97M | -$8.70M |
$13.65
▼ -0.10 (-0.7%)
| 52w hi | $18.49 |
|---|---|
| 52w lo | $13.30 |
| Vol | 451.05K |
| As of | Aug 13 |
Our score -0.10
| Short | -0.98 |
|---|---|
| Medium | +0.20 |
| Long | +1.03 |
computed 2026-08-13
Eckert & Ziegler SE
Healthcare · Medical Devices
| Market cap | $854.17M |
|---|---|
| Enterprise value | $774.83M |
| Trailing P/E | 17.28x |
| Forward P/E | 15.53x |
| EV / EBITDA | 8.56x |
| P / S (ttm) | 2.70x |
| Profit margin | 15.6% |
| Return on equity | 19.8% |
| Revenue growth | +7.0% |
| Earnings growth | +6.9% |
| Debt / equity | 16.05 |
| Beta vs SPX | 0.38 |
|---|---|
| Corr SPX | 0.17 |
| Annual vol | 36.1% |
| Annual ret | +12.2% |
| Sharpe | 0.34 |
| Max DD | -40.1% |
Window: 504 trading days (489 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.56 | |
| Sector | +0.12 | |
| Technical | +0.00 | |
| Earnings | +0.00 | |
| Sentiment | -0.93 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $13.85 | $13.92 | $13.22 | $13.65 | 451.05K |
| Aug 12 | $13.81 | $13.89 | $13.73 | $13.75 | 57.82K |
| Aug 11 | $14.01 | $14.04 | $13.87 | $13.94 | 58.44K |
| Aug 10 | $14.05 | $14.05 | $13.84 | $13.90 | 59.91K |
| Aug 7 | $13.75 | $14.11 | $13.74 | $13.90 | 108.83K |